GO:0070062 extracellular exosome: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070062 extracellular exosome describes small vesicles (about 40-100 nm) released into the extracellular region by fusion of the multivesicular body membrane with the plasma membrane.
• Exosomes carry a complex cargo of proteins, lipids, RNA and DNA that reflects their cell of origin and can alter recipient cell behaviour.
• Biogenesis proceeds through endosomal sorting complexes required for transport (ESCRT)-dependent and ESCRT-independent routes, followed by MVB-plasma membrane fusion and release.
• Exosome composition is heterogeneous; rigorous isolation and characterization are essential because co-isolating particles can confound functional conclusions.
• Exosomes are implicated in cancer, neurodegeneration, intervertebral disc degeneration and other pathologies, making them attractive for diagnostics and therapeutics.
• CRISPR knockout, knock-in, point-mutation and overexpression models enable causal dissection of exosome biogenesis, cargo sorting and uptake.
Description
GO:0070062 extracellular exosome is a cellular component term that defines a vesicle released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. These vesicles, commonly called exosomes, have a diameter of about 40-100 nm and are a subtype of extracellular vesicle. Because they carry proteins, lipids, and nucleic acids derived from the parent cell, exosomes are now recognized as key mediators of intercellular communication in both physiology and disease. Researchers study extracellular exosomes to understand how cells package and deliver molecular information, and to exploit them as biomarkers or therapeutic vehicles. The term is therefore central to cell biology, immunology, neuroscience, and oncology, and it is increasingly used in generative-AI queries about vesicle trafficking and non-coding RNA delivery. Accurate annotation of proteins to GO:0070062 depends on experimental evidence of vesicular release and density gradient or size-based isolation, as reviewed in exosome processing guidelines.
extracellular exosome At A Glance
| GO ID | GO:0070062 |
|---|---|
| GO term | extracellular exosome |
| Ontology | cellular_component |
| Synonym | exosome; extracellular vesicular exosome |
| Definition | A vesicle released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane; diameter about 40-100 nm |
| Major function | Intercellular transport of proteins, lipids, RNA and DNA; cell-cell communication; waste and cargo disposal |
| Biogenesis route | Endosomal sorting complexes required for transport (ESCRT)-dependent and ESCRT-independent pathways |
| Size range | Approximately 40-100 nm |
| Common markers | Tetraspanins (CD9, CD63, CD81), ALIX, TSG101, syntenin-1 |
What Is GO:0070062?
In simple terms, an extracellular exosome is a tiny bubble that a cell spits out after fusing an internal endosomal compartment with its surface. According to the QuickGO definition, it is a vesicle released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane, with a diameter of about 40-100 nm. The term is a cellular component annotation and includes the synonyms exosome and extracellular vesicular exosome. It should not be confused with the exosome complex (a ribonuclease machine) or with other extracellular vesicles such as microvesicles and apoptotic bodies, which have different biogenesis routes.
Why Is extracellular exosome Important in Cell Biology?
Extracellular exosomes are important because they provide a mechanism for cells to exchange molecular information over distance without direct contact, and because their cargo can be used to diagnose disease or to deliver therapeutics. The term GO:0070062 is heavily used in proteomics and transcriptomics annotation, and it helps researchers distinguish bona fide exosomal cargo from co-isolating contaminants. Understanding exosome biology is therefore essential for interpreting extracellular vesicle data and for developing exosome-based interventions in cancer, neurodegeneration, and regenerative medicine.
• Exosomes mediate intercellular communication by transferring proteins, lipids, and nucleic acids to recipient cells.
• They are implicated in cancer progression, metastasis, and drug resistance through cargo transfer.
• Exosomes contribute to neurodegeneration and are being explored as biomarkers and therapeutics in Alzheimer's disease.
• They participate in intervertebral disc degeneration and can regulate pyroptosis and metabolism.
• Exosome composition is heterogeneous, so rigorous isolation and characterization are required for reproducible research.
• Plant-derived exosome-like nanoparticles expand the concept of extracellular vesicles beyond mammalian systems.
• Exosomes are candidate delivery vehicles for RNA, protein, and small-molecule therapeutics.
• GO:0070062 annotations support functional enrichment analysis in proteomics and single-cell studies.
• Exosome biogenesis intersects with endosomal trafficking, autophagy, and immune surveillance.
• CRISPR-based models enable causal testing of exosome-related genes in disease contexts.
What Happens During extracellular exosome biogenesis, cargo sorting, release and uptake?
Initiation at the endosomal membrane
In simple terms: The cell starts by invaginating its endosomal membrane inward to form tiny buds.
Exosome biogenesis begins when the limiting membrane of a late endosome invaginates to form intraluminal vesicles (ILVs) within a multivesicular body (MVB). This process is driven by ESCRT complexes (ESCRT-0, -I, -II, -III) and associated proteins such as TSG101 and ALIX, although ESCRT-independent routes involving tetraspanins and ceramide also operate. The resulting ILVs are the immediate precursors of exosomes, and their cargo is selected during this inward budding step.
Cargo sorting into intraluminal vesicles
In simple terms: Specific proteins and RNAs are tagged and packed into the tiny internal bubbles.
Cargo sorting into ILVs is selective and depends on sorting motifs, ubiquitination, and lipid microdomains. Tetraspanins such as CD9, CD63, and CD81 are enriched on exosomes and serve as canonical markers, while ALIX and syntenin-1 participate in cargo recruitment. RNA-binding proteins and membrane anchors help concentrate specific RNAs and proteins into exosomes, contributing to the heterogeneous composition observed across cell types.
MVB fusion with the plasma membrane
In simple terms: The loaded multivesicular body travels to the cell surface and merges with it, spilling the tiny bubbles outside.
Once ILVs are formed, the MVB is transported to the plasma membrane, where the limiting membrane fuses with the plasma membrane in a process requiring Rab GTPases, SNARE proteins, and calcium-dependent machinery. This fusion event releases the ILVs into the extracellular space, where they are then called exosomes. The release step is regulated and can be modulated by extracellular signals and cellular stress.
Uptake by recipient cells
In simple terms: The released exosome reaches another cell and delivers its cargo inside.
Exosomes can be taken up by recipient cells through endocytosis, phagocytosis, macropinocytosis, or direct membrane fusion. Uptake specificity depends on surface molecules such as integrins and tetraspanins, and the delivered cargo can alter recipient cell signalling, gene expression, and phenotype. This uptake step is a key node for therapeutic intervention and for understanding disease propagation.
Composition and heterogeneity
In simple terms: Exosomes are not all the same; their contents vary depending on the cell and conditions.
Reassessment of exosome composition has shown that exosomes contain a complex and variable set of proteins, lipids, and nucleic acids, with some commonly cited markers being less specific than previously thought. Proteomic and RNA profiling studies reveal that exosome cargo reflects the parent cell state and can be altered by disease or treatment. This heterogeneity underscores the need for standardized isolation and characterization methods in exosome research.
Key Genes Involved in GO:0070062 extracellular exosome
The following genes and proteins are experimentally implicated in extracellular exosome biogenesis, cargo sorting, release, or uptake, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD9 | Tetraspanin marker and organizer of exosomal membrane microdomains | Common exosome marker for isolation and characterization |
| CD63 | Tetraspanin enriched on exosomes and ILVs | Canonical exosome marker used in flow cytometry and imaging |
| CD81 | Tetraspanin involved in membrane organization and cargo sorting | Exosome marker and potential target for uptake studies |
| TSG101 | ESCRT-I component required for MVB formation | Functional readout for ESCRT-dependent biogenesis |
| ALIX (PDCD6IP) | ESCRT-associated protein involved in ILV formation and cargo recruitment | Key regulator of exosome biogenesis and marker |
| SDCBP (syntenin-1) | Adaptor linking cargo to ESCRT machinery | Exosome marker and regulator of cargo sorting |
| RAB27A | Rab GTPase mediating MVB docking and fusion with plasma membrane | Regulates exosome release; knockout reduces secretion |
| RAB27B | Rab GTPase involved in exosome secretion | Modulates release in specific cell types |
| RAB11A | Rab GTPase implicated in MVB trafficking | Potential regulator of exosome release |
| RAB35 | Rab GTPase controlling exosome secretion | Target for modulating exosome output |
| SNAP23 | SNARE protein involved in MVB-plasma membrane fusion | Fusion machinery component for exosome release |
| VAMP7 | SNARE protein mediating membrane fusion | Regulates exosome secretion in some cell types |
| HSPA8 (HSC70) | Chaperone involved in ESCRT-independent sorting | Cargo sorting and exosome marker |
| HSP90AA1 | Chaperone found in exosomes | Stress-related cargo and potential biomarker |
| ACTB | Cytoskeletal protein commonly detected in exosome preparations | Frequent contaminant or bona fide cargo depending on isolation |
| GAPDH | Glycolytic enzyme often detected in exosomes | Common marker but also a contamination indicator |
| FLOT1 | Flotillin involved in ESCRT-independent ILV formation | Alternative biogenesis pathway component |
| CD47 | Integrin-associated protein that inhibits phagocytosis | Enhances exosome circulation half-life for therapeutics |
How Is extracellular exosome Regulated?
Exosome biogenesis and release are regulated at multiple levels. ESCRT-dependent and ESCRT-independent pathways are controlled by the availability of components such as TSG101, ALIX, and tetraspanins, and by lipid metabolism. Rab GTPases, including RAB27A and RAB27B, regulate MVB docking and fusion with the plasma membrane, and their activity can be modulated by cellular signals. Calcium signalling and SNARE-mediated fusion events also influence release rates. In disease contexts, exosome secretion can be altered by oncogenic signalling and stress responses, and exosome cargo can change with the cellular state. Standardized isolation and characterization are required to distinguish true regulatory effects from technical variability.
extracellular exosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAB27A | Cancer exosome secretion and metastasis | Knockout in cancer cell lines followed by exosome quantification |
| CD63 | Neurodegenerative disease biomarker | Knock-in of fluorescent tag for exosome tracking |
| ALIX (PDCD6IP) | Intervertebral disc degeneration and pyroptosis | Overexpression in degenerative cell models |
| TSG101 | Cancer exosome biogenesis | Point mutation to disrupt ESCRT function |
| CD47 | Exosome therapeutic half-life | Knock-in of CD47 fusion for enhanced circulation |
Cancer
Exosomes are implicated in cancer progression, metastasis, and drug resistance because they transfer oncogenic proteins, RNAs, and lipids between tumour cells and the tumour microenvironment. Exosome-mediated communication can reprogram recipient cells and promote angiogenesis and immune evasion. Consequently, exosome cargo is being explored as a source of cancer biomarkers and as a therapeutic target.
Neurodegenerative disease
In Alzheimer's disease and other neurodegenerative conditions, exosomes contribute to the spread of pathological proteins and are being investigated as neuroprotective or therapeutic vehicles. Exosome-based therapeutics are being developed to deliver neuroprotective cargo and to modulate neuroinflammation. The role of exosomes in disease propagation makes them attractive both as biomarkers and as intervention points.
Musculoskeletal degeneration
Exosome-functionalized hydrogels have been used to regulate metabolism and pyroptosis in intervertebral disc degeneration, suggesting that exosomes can modulate degenerative processes in musculoskeletal tissues. This illustrates the broader potential of exosome-based materials for tissue repair and regeneration.
Plant-derived exosome-like nanoparticles
Plant-derived exosome-like nanoparticles are being studied for their therapeutic and delivery properties, extending exosome biology beyond mammalian systems. Research in this area highlights both opportunities and challenges in translating exosome-like vesicles into clinical applications.
From extracellular exosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for exosome release? | CRISPR knockout in a relevant cell line followed by nanoparticle tracking analysis |
| Does a specific mutation alter exosome cargo sorting? | Point-mutation knock-in of the sorting motif |
| Can a tagged protein be tracked in exosomes? | Knock-in of a fluorescent or epitope tag |
| Does overexpression of a gene increase exosome production? | Stable overexpression cell line |
| Which genes regulate exosome uptake? | CRISPR library screening in recipient cells |
| Does a disease-associated variant affect exosome secretion? | Isogenic point-mutation model |
How to Study the extracellular exosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nanoparticle tracking analysis | Size and concentration of vesicles | Exosome release quantification |
| Transmission electron microscopy | Morphology and size of exosomes | Ultrastructural validation |
| Western blot | Presence of exosome markers | Confirmation of isolation |
| Mass spectrometry | Protein cargo composition | Biomarker discovery |
| RNA sequencing | RNA cargo profiles | Functional cargo analysis |
| Fluorescence microscopy | MVB and exosome trafficking | Live-cell imaging of release |
| Flow cytometry | Surface markers on exosomes | Phenotyping and uptake studies |
Isolation and characterization
Exosomes are typically isolated by differential ultracentrifugation, density gradient, size-exclusion chromatography, or immunoaffinity capture, and characterized by nanoparticle tracking analysis, electron microscopy, and Western blotting for markers such as CD9, CD63, and CD81. Standardized protocols are essential because co-isolating particles can confound downstream analyses.
Proteomics and cargo profiling
Mass spectrometry-based proteomics and RNA sequencing are used to profile exosome cargo and to identify disease-associated signatures. Reassessment studies have refined the list of bona fide exosomal proteins and highlighted the importance of controls.
Imaging and tracking
Fluorescent tagging of tetraspanins or cargo proteins enables live-cell imaging of MVB dynamics and exosome release, while super-resolution microscopy can resolve ILV formation. These approaches help link specific genes to distinct steps in the exosome pathway.
Functional uptake assays
Recipient cells can be treated with labelled exosomes to measure uptake efficiency and downstream signalling changes. Such assays are used to test whether exosome-mediated communication is altered by genetic perturbations.
How CRISPR Can Be Used to Study GO:0070062 extracellular exosome
Knockout
CRISPR knockout of genes such as RAB27A, TSG101, or ALIX can abolish or reduce exosome release, providing causal evidence for their role in biogenesis. Knockout models are also used to test whether a candidate gene is required for cargo sorting or uptake.
Point Mutation
Point mutations can be introduced to disrupt specific sorting motifs or catalytic residues without eliminating the protein, allowing fine mapping of exosome-related functions. Isogenic point-mutation models are valuable for studying disease-associated variants.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous loci enables tracking of exosome proteins at physiological expression levels. This approach is useful for imaging MVB dynamics and for isolating tagged exosomes.
Overexpression
Overexpression of exosome-related genes can increase exosome production or alter cargo composition, and is often used to test therapeutic potential. Overexpression models complement knockout studies by revealing gain-of-function effects.
How EDITGENE Supports extracellular exosome Research
Researchers studying extracellular exosome-related genes often need to determine whether a candidate gene is causally involved in vesicle biogenesis, cargo sorting, release, or uptake. EDITGENE provides CRISPR-based cell model services that enable such causal experiments with reproducible, publication-ready reagents.
Contact EDITGENE today to design your custom CRISPR model for extracellular exosome research.
Frequently Asked Questions About extracellular exosome
What is GO:0070062 extracellular exosome?
GO:0070062 is a cellular component term describing a vesicle released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane, with a diameter of about 40-100 nm.
What genes are involved in extracellular exosome biogenesis?
Key genes include RAB27A, RAB27B, TSG101, ALIX (PDCD6IP), CD9, CD63, CD81, and SDCBP (syntenin-1), which participate in MVB formation, cargo sorting, and release.
How are exosomes different from other extracellular vesicles?
Exosomes originate from the endosomal system via multivesicular body fusion with the plasma membrane, whereas microvesicles bud directly from the plasma membrane and apoptotic bodies arise during cell death.
What is the size of an extracellular exosome?
Extracellular exosomes have a diameter of about 40-100 nm according to the QuickGO definition.
What markers are used to identify exosomes?
Common markers include tetraspanins CD9, CD63, and CD81, as well as ALIX, TSG101, and syntenin-1, although none is entirely specific.
How can I study exosome release in the lab?
Exosome release can be studied by isolating vesicles via ultracentrifugation or size-exclusion chromatography and quantifying them with nanoparticle tracking analysis, electron microscopy, and Western blotting.
What diseases are associated with extracellular exosomes?
Exosomes are implicated in cancer, neurodegenerative diseases such as Alzheimer's disease, intervertebral disc degeneration, and other conditions.
Can CRISPR be used to study exosome genes?
Yes, CRISPR knockout, knock-in, point-mutation, and overexpression models are widely used to dissect exosome biogenesis, cargo sorting, and uptake.
What is the role of RAB27A in exosomes?
RAB27A is a Rab GTPase that mediates multivesicular body docking and fusion with the plasma membrane, thereby regulating exosome release.
How does EDITGENE support exosome research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for exosome-related genes.
Conclusion
GO:0070062 extracellular exosome defines a biologically important class of vesicles that mediate intercellular communication and are implicated in diverse diseases. Understanding their biogenesis, cargo, and uptake requires rigorous experimental models and standardized methods. CRISPR-based approaches, combined with proteomics and imaging, provide a powerful framework for causal dissection of exosome biology. EDITGENE offers the cell model and screening services needed to accelerate this research.
References
- 1. Doyle LM et al.. 2019. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis.. Cells 8(7) PMID: 31311206
- 2. Lai JJ et al.. 2022. Exosome Processing and Characterization Approaches for Research and Technology Development.. Adv Sci (Weinh) 9(15):e2103222 PMID: 35332686
- 3. Jeppesen DK et al.. 2019. Reassessment of Exosome Composition.. Cell 177(2):428-445.e18 PMID: 30951670
- 4. Gurung S et al.. 2021. The exosome journey: from biogenesis to uptake and intracellular signalling.. Cell Commun Signal 19(1):47 PMID: 33892745
- 5. Ebadpour N et al.. 2025. Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer's Disease: Neuroprotective Roles and Future Perspectives.. J Mol Neurosci 75(4):137 PMID: 41076604
- 6. Xing H et al.. 2021. Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration.. J Nanobiotechnology 19(1):264 PMID: 34488795
- 7. He C et al.. 2018. Exosome Theranostics: Biology and Translational Medicine.. Theranostics 8(1):237-255 PMID: 29290805
- 8. Bai C et al.. 2024. Research status and challenges of plant-derived exosome-like nanoparticles.. Biomed Pharmacother 174:116543 PMID: 38608523
